Cervico-Vaginal Immunoglobulin G Levels Increase Post-Ovulation Independently of Neutrophils

por Schaefer, Katrein, Brown, Najmeeyah, Kaye, Paul M., Lacey, Charles J.
Publicado 2014

Vaccines against leishmaniasis: using controlled human infection models to accelerate development

por Parkash, Vivak, Kaye, Paul M., Layton, Alison M, Lacey, Charles J
Publicado 2021

Two cases of possible transmitted drug-resistant HIV: likely HIV superinfection and unmasking of pre-existing resistance

por Martin, Fabiola, Lee, John, Thomson, Emma, Tarrant, Nick, Hale, Antony, Lacey, Charles J
Publicado 2016

Assessing public perception of a sand fly biting study on the pathway to a controlled human infection model for cutaneous leishmaniasis

por Parkash, Vivak, Jones, Georgina, Martin, Nina, Steigmann, Morgan, Greensted, Elizabeth, Kaye, Paul, Layton, Alison M., Lacey, Charles J.
Publicado 2021

Frequency and risk factors for prevalent, incident, and persistent genital carcinogenic human papillomavirus infection in sexually active women: community based cohort study

por Oakeshott, Pippa, Aghaizu, Adamma, Reid, Fiona, Howell-Jones, Rebecca, Hay, Phillip E, Sadiq, S Tariq, Lacey, Charles J, Beddows, Simon, Soldan, Kate
Publicado 2012

Recombinant polymorphic membrane protein D in combination with a novel, second-generation lipid adjuvant protects against intra-vaginal Chlamydia trachomatis infection in mice

por Paes, Wayne, Brown, Naj, Brzozowski, Andrzej M., Coler, Rhea, Reed, Steve, Carter, Darrick, Bland, Martin, Kaye, Paul M., Lacey, Charles J.N.
Publicado 2016

MABGEL 1: First Phase 1 Trial of the Anti-HIV-1 Monoclonal Antibodies 2F5, 4E10 and 2G12 as a Vaginal Microbicide

por Morris, Georgina C., Wiggins, Rebecca C., Woodhall, Sarah C., Bland, J. Martin, Taylor, Carol R., Jespers, Vicky, Vcelar, Brigitta A., Lacey, Charles J.
Publicado 2014

Overcoming roadblocks in the development of vaccines for leishmaniasis

por Kaye, Paul M., Mohan, Sakshi, Mantel, Carsten, Malhame, Melissa, Revill, Paul, Le Rutte, Epke, Parkash, Vivak, Layton, Alison M., Lacey, Charles J.N., Malvolti, Stefano
Publicado 2021

A dose-reduction HPV vaccine immunobridging trial of two HPV vaccines among adolescent girls in Tanzania (the DoRIS trial) – Study protocol for a randomised controlled trial

por Baisley, Kathy J., Whitworth, Hilary S., Changalucha, John, Pinto, Ligia, Dillner, Joakim, Kapiga, Saidi, de Sanjosé, Silvia, Mayaud, Philippe, Hayes, Richard J., Lacey, Charles J., Watson-Jones, Deborah
Publicado 2021

A third generation vaccine for human visceral leishmaniasis and post kala azar dermal leishmaniasis: First-in-human trial of ChAd63-KH

por Osman, Mohamed, Mistry, Anoop, Keding, Ada, Gabe, Rhian, Cook, Elizabeth, Forrester, Sarah, Wiggins, Rebecca, Di Marco, Stefania, Colloca, Stefano, Siani, Loredana, Cortese, Riccardo, Smith, Deborah F., Aebischer, Toni, Kaye, Paul M., Lacey, Charles J.
Publicado 2017

Phase I Randomised Clinical Trial of an HIV-1(CN54), Clade C, Trimeric Envelope Vaccine Candidate Delivered Vaginally

por Lewis, David J., Fraser, Carol A., Mahmoud, Abdel N., Wiggins, Rebecca C., Woodrow, Maria, Cope, Alethea, Cai, Chun, Giemza, Rafaela, Jeffs, Simon A., Manoussaka, Maria, Cole, Tom, Cranage, Martin P., Shattock, Robin J., Lacey, Charles J.
Publicado 2011

A clinical study to optimise a sand fly biting protocol for use in a controlled human infection model of cutaneous leishmaniasis (the FLYBITE study)

por Parkash, Vivak, Ashwin, Helen, Sadlova, Jovana, Vojtkova, Barbora, Jones, Georgina, Martin, Nina, Greensted, Elizabeth, Allgar, Victoria, Kamhawi, Shaden, Valenzuela, Jesus G., Layton, Alison M., Jaffe, Charles L., Volf, Petr, Kaye, Paul M., Lacey, Charles J. N.
Publicado 2021

Characterization of a new Leishmania major strain for use in a controlled human infection model

por Ashwin, Helen, Sadlova, Jovana, Vojtkova, Barbora, Becvar, Tomas, Lypaczewski, Patrick, Schwartz, Eli, Greensted, Elizabeth, Van Bocxlaer, Katrien, Pasin, Marion, Lipinski, Kai S., Parkash, Vivak, Matlashewski, Greg, Layton, Alison M., Lacey, Charles J., Jaffe, Charles L., Volf, Petr, Kaye, Paul M.
Publicado 2021

PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial

por McCormack, Sheena, Ramjee, Gita, Kamali, Anatoli, Rees, Helen, Crook, Angela M, Gafos, Mitzy, Jentsch, Ute, Pool, Robert, Chisembele, Maureen, Kapiga, Saidi, Mutemwa, Richard, Vallely, Andrew, Palanee, Thesla, Sookrajh, Yuki, Lacey, Charles J, Darbyshire, Janet, Grosskurth, Heiner, Profy, Albert, Nunn, Andrew, Hayes, Richard, Weber, Jonathan
Publicado 2010

Comparing one dose of HPV vaccine in girls aged 9–14 years in Tanzania (DoRIS) with one dose of HPV vaccine in historical cohorts: an immunobridging analysis of a randomised contro...

por Baisley, Kathy, Kemp, Troy J, Kreimer, Aimée R, Basu, Partha, Changalucha, John, Hildesheim, Allan, Porras, Carolina, Whitworth, Hilary, Herrero, Rolando, Lacey, Charles J, Schiller, John T, Lucas, Eric, Mutani, Paul, Dillner, Joakim, Indangasi, Jackton, Muwonge, Richard, Hayes, Richard J, Pinto, Ligia A, Watson-Jones, Deborah
Publicado 2022

Safety and immunogenicity of ChAd63-KH vaccine in post-kala-azar dermal leishmaniasis patients in Sudan

por Younis, Brima M., Osman, Mohamed, Khalil, Eltahir A.G., Santoro, Francesco, Furini, Simone, Wiggins, Rebecca, Keding, Ada, Carraro, Monica, Musa, Anas E.A., Abdarahaman, Mujahid A.A., Mandefield, Laura, Bland, Martin, Aebischer, Toni, Gabe, Rhian, Layton, Alison M., Lacey, Charles J.N., Kaye, Paul M., Musa, Ahmed M.
Publicado 2021

Immunogenicity and safety of one-dose human papillomavirus vaccine compared with two or three doses in Tanzanian girls (DoRIS): an open-label, randomised, non-inferiority trial

por Watson-Jones, Deborah, Changalucha, John, Whitworth, Hilary, Pinto, Ligia, Mutani, Paul, Indangasi, Jackton, Kemp, Troy, Hashim, Ramadhan, Kamala, Beatrice, Wiggins, Rebecca, Songoro, Twaib, Connor, Nicholas, Mbwanji, Gladys, Pavon, Miquel A, Lowe, Brett, Mmbando, Devis, Kapiga, Saidi, Mayaud, Philippe, de SanJosé, Silvia, Dillner, Joakim, Hayes, Richard J, Lacey, Charles J, Baisley, Kathy
Publicado 2022

Comparative Immunogenicity of HIV-1 gp140 Vaccine Delivered by Parenteral, and Mucosal Routes in Female Volunteers; MUCOVAC2, A Randomized Two Centre Study

por Cosgrove, Catherine A., Lacey, Charles J., Cope, Alethea V., Bartolf, Angela, Morris, Georgina, Yan, Celine, Baden, Susan, Cole, Tom, Carter, Darrick, Brodnicki, Elizabeth, Shen, Xiaoying, Joseph, Sarah, DeRosa, Stephen C., Peng, Lili, Yu, Xuesong, Ferrari, Guido, Seaman, Mike, Montefiori, David C., Frahm, Nicole, Tomaras, Georgia D., Stöhr, Wolfgang, McCormack, Sheena, Shattock, Robin J.
Publicado 2016

An analysis of baseline data from the PROUD study: an open-label randomised trial of pre-exposure prophylaxis

por Dolling, David I., Desai, Monica, McOwan, Alan, Gilson, Richard, Clarke, Amanda, Fisher, Martin, Schembri, Gabriel, Sullivan, Ann K., Mackie, Nicola, Reeves, Iain, Portman, Mags, Saunders, John, Fox, Julie, Bayley, Jake, Brady, Michael, Bowman, Christine, Lacey, Charles J., Taylor, Stephen, White, David, Antonucci, Simone, Gafos, Mitzy, McCormack, Sheena, Gill, Owen N., Dunn, David T., Nardone, Anthony
Publicado 2016

Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial

por McCormack, Sheena, Dunn, David T, Desai, Monica, Dolling, David I, Gafos, Mitzy, Gilson, Richard, Sullivan, Ann K, Clarke, Amanda, Reeves, Iain, Schembri, Gabriel, Mackie, Nicola, Bowman, Christine, Lacey, Charles J, Apea, Vanessa, Brady, Michael, Fox, Julie, Taylor, Stephen, Antonucci, Simone, Khoo, Saye H, Rooney, James, Nardone, Anthony, Fisher, Martin, McOwan, Alan, Phillips, Andrew N, Johnson, Anne M, Gazzard, Brian, Gill, Owen N
Publicado 2016